Organization | Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento

Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2012

NCT01784549

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Alternative names

Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento | Azienda Sanitaria per i Servizi Sanitari della Provincia Autonoma di Trento

Active Ingredients

Drugs in Phase 2 Trials (6)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

gefitinib (iressa) (1 trial)

gemcitabine (gemzar) (1 trial)

pemetrexed (alimta) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Other Trials (1)

aleurone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 2
# of Trial APIs: 7